Rapid determination of gefitinib and its main metabolite, O-desmethyl gefitinib in human plasma using liquid chromatography-tandem mass spectrometry

by Wang, L.-Z., Lim, M.Y.-X., Chin, T.-M., Thuya, W.-L., Nye, P.-L., Wong, A., Chan, S.-Y., Goh, B.-C., Ho, P.C.
Published 2014

Method development and validation for rapid quantification of hydroxychloroquine in human blood using liquid chromatography-tandem mass spectrometry

by Wang, L.-Z., Ong, R.Y.-L., Chin, T.-M., Thuya, W.-L., Wan, S.-C., Wong, A.L.A., Chan, S.-Y., Ho, P.C., Goh, B.-C.
Published 2014

Simultaneous determination of raltegravir and raltegravir glucuronide in human plasma by liquid chromatography-tandem mass spectrometric method

by Wang, L.-Z., Lee, L.S.-U., Thuya, W.-L., Soon, G.H., Kong, L.-R., Nye, P.-L., Deoon Lee, E.J., Flexner, C., Goh, B.-C.
Published 2014

Quantification of L-ergothioneine in human plasma and erythrocytes by liquid chromatography-tandem mass spectrometry

by Wang, L.-Z., Thuya, W.-L., Toh, D.S.-L., Lie, M.G.-L., Lau, J.-Y.A., Kong, L.-R., Wan, S.-C., Chua, K.-N., Lee, E.J.-D., Goh, B.-C.
Published 2014

A sensitive liquid chromatography-tandem mass spectrometry method for the determination of nimbolide in mouse serum: Application to a preclinical pharmacokinetics study

by Wang, L, Khoa Phan, D.-D, Syn, N, Xiang, X, Song, H, Thuya, W.L, Yang, S, Wong, A.L.-A, Kumar, A.P, Yong, W.P, Sethi, G, Ho, P.C.-L, Goh, B.C
Published 2020

Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development

by Wang, L, Khoa Phan, D.D, Zhang, J, Ong, P.-S, Thuya, W.L, Soo, R.A, Wong, A.L.-A, Yong, W.P, Lee, S.C, Ho, P.C.-L, Sethi, G, Goh, B.C
Published 2020

Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor

by Subhash, V.V, Yeo, M.S, Wang, L, Tan, S.H, Wong, F.Y, Thuya, W.L, Tan, W.L, Peethala, P.C, Soe, M.Y, Tan, D.S.P, Padmanabhan, N, Baloglu, E, Shacham, S, Tan, P, Koeffler, H.P, Yong, W.P
Published 2020

Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients

by Wang, L.-Z., Ramírez, J., Yeo, W., Chan, M.-Y.M., Thuya, W.-L., Lau, J.-Y.A., Wan, S.-C., Wong, A.L.-A., Zee, Y.-K., Lim, R., Lee, S.-C., Ho, P.C., Lee, H.-S., Chan, A., Ansher, S., Ratain, M.J., Goh, B.-C.
Published 2014